Wild type and YMDD variant of hepatitis B virus: No difference in viral kinetics on lamivudine/tenofovir therapy in HIV-HBV co-infected patients

Journal of Clinical Virology

Volumn 36, Issue 1, 2006, Pages 60-63

  de Vries Sluijs, T E M S ^a   van der Eijk, A A ^a   Hansen, B E ^a   Osterhaus, A D M E ^a   de Man, R A ^a   van der Ende, M E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

HBV; HIV; Lamivudine; Tenofovir; Viral dynamics; YMDD

Indexed keywords

LAMIVUDINE; TENOFOVIR; ADENINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DRUG DERIVATIVE; PHOSPHONIC ACID DERIVATIVE; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KINETICS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; VIRUS MUTATION; VIRUS RESISTANCE; WILD TYPE; ANTIBIOTIC RESISTANCE; BLOOD; COMPARATIVE STUDY; DRUG EFFECT; GENETIC VARIABILITY; GENETICS; MALE; MIDDLE AGED;

ADENINE; ADULT; ANTI-HIV AGENTS; DNA, VIRAL; DRUG RESISTANCE, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HIV INFECTIONS; HUMANS; KINETICS; LAMIVUDINE; MALE; MIDDLE AGED; PHOSPHONIC ACIDS; RNA, VIRAL; VARIATION (GENETICS);

EID: 33744536003     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2005.12.004     Document Type: Article

References (20)

1. Benhamou Y., Tubiana R., and Thibault V. Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus. N Engl J Med 348 2 (2003) 177-178
2. Colin J.F., Cazals-Hatem D., Loriot M.A., Martinot-Peignoux M., Pham B.N., Auperin A., et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 29 4 (1999) 1306-1310
3. Delaney W.Et., Yang H., Miller M.D., Gibbs C.S., and Xiong S. Combinations of adefovir with nucleoside analogs produce additive antiviral effects against hepatitis B virus in vitro. Antimicrob Agents Chemother 48 10 (2004) 3702-3710
4. Gilson R.J., Hawkins A.E., Beecham M.R., Ross E., Waite J., Briggs M., et al. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. Aids 11 5 (1997) 597-606
5. Heermann K.H., Gerlich W.H., Chudy M., Schaefer S., and Thomssen R. Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. Eurohep Pathobiology Group. J Clin Microbiol 37 1 (1999) 68-73
6. Lacombe K., Gozlan J., Boelle P.Y., Serfaty L., Zoulim F., Valleron A.J., et al. Long-term hepatitis B virus dynamics in HIV-hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate. Aids 19 9 (2005) 907-915
7. Leung N.W., Lai C.L., Chang T.T., Guan R., Lee C.M., Ng K.Y., et al. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology 33 6 (2001) 1527-1532
8. Lewin S.R., Ribeiro R.M., Walters T., Lau G.K., Bowden S., Locarnini S., et al. Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed. Hepatology 34 5 (2001) 1012-1020
9. Neumann A.U., Lam N.P., Dahari H., Gretch D.R., Wiley T.J., Layden T.J., et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282 5386 (1998) 103-107
10. Nowak M.A., Bonhoeffer S., Hill A.M., Boehme R., Thomas H.C., and McDade H. Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci USA 93 9 (1996) 4398-4402
11. Osterhaus A.D., Vos M.C., Balk A.H., de Man R.A., Mouton J.W., Rothbarth P.H., et al. Transmission of hepatitis B virus among heart transplant recipients during endomyocardial biopsy procedures. J Heart Lung Transplant 17 2 (1998) 158-166
12. Pas S.D., Fries E., De Man R.A., Osterhaus A.D., and Niesters H.G. Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays. J Clin Microbiol 38 8 (2000) 2897-2901
13. Stuyver L., Van Geyt C., De Gendt S., Van Reybroeck G., Zoulim F., Leroux-Roels G., et al. Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy. J Clin Microbiol 38 2 (2000) 702-707
14. Tsiang M., Rooney J.F., Toole J.J., and Gibbs C.S. Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy. Hepatology 29 6 (1999) 1863-1869
15. van Bommel F., Wunsche T., Schurmann D., and Berg T. Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication. Hepatology 36 2 (2002) 507-508
16. van der Eijk A.A., Hansen B.E., Niesters H.G., Janssen H.L., Ende M., Schalm S.W., et al. Viral dynamics during tenofovir therapy in patients infected with lamivudine-resistant hepatitis B virus mutants. J Viral Hepat 12 4 (2005) 364-372
17. Wolters L.M., Hansen B.E., Niesters H.G., Levi-Drummer R.S., Neumann A.U., Schalm S.W., et al. The influence of baseline characteristics on viral dynamic parameters in chronic hepatitis B patients treated with lamivudine. J Hepatol 37 2 (2002) 253-258
18. Wolters L.M., Hansen B.E., Niesters H.G., Zeuzem S., Schalm S.W., and de Man R.A. Viral dynamics in chronic hepatitis B patients during lamivudine therapy. Liver 22 2 (2002) 121-126
19. Wolters L.M., Niesters H.G., Hansen B.E., van der Ende M.E., Kroon F.P., Richter C., et al. Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort. J Clin Virol 24 3 (2002) 173-181
20. Ying C., De Clercq E., Nicholson W., Furman P., and Neyts J. Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, l-FMAU, DAPD, penciclovir and lobucavir. J Viral Hepatitis 7 2 (2000) 161-165